In addition, he makes 4,196,910$ as Group President - Global Businesses and Americas at Zimmer Biomet Inc. Elizabeth Hofheinz, M.P.H., M.Ed. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Gl obal Urology, Medical and Critical Care Division of Becton, Dickinson and Company. | March 27, 2022 Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities . 574-372-4989 Cautionary Note Regarding Forward-Looking Statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC. Andrews Medicine Clinic and Celltex Therapeutics have formed a new company named Andrews Celltex Biologics. Media Coleman Lannum ", Prior to his time at Zimmer Biomet, Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Before that, Tornos held several positions with C.R. Joining me today are Bryan Hanson, our Chairman, President and CEO; EVP and CFO, Suky Upadhyay; and COO, Ivan Tornos. Learn how your comment data is processed. Earlier, he was with C.R. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The Company also announced today that Didier Deltort, who has served as the President of EMEA since August 2018, will be departing Zimmer Biomet for another professional appointment. Sitemap. Ivan Tornos Chief Operating Officer Kenneth R. Tripp Senior Vice President, Global Operations and Logistics Suketu Upadhyay Executive Vice President and Chief Financial Officer Sang Yi President, Asia Pacific Lori Winkler Senior Vice President and Chief Human Resources Officer Wilfred van Zuilen President, Europe, Middle East and Africa Before joining C.R. On this week's episode of DeviceTalks, our Chief Operating Officer Ivan Tornos shares the latest updates to our innovative portfolio and dives into how we . In this newly created position, Mr. Tornos will be responsible for increased innovation, implementation and execution of the Orthopedics group, which will include our large joint, sports, extremities and trauma (S.E.T.) A search is underway for a new President of the EMEA region. He finalized post-MBA work at the Wharton School of the University of Pennsylvania, holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business., We asked Mr. Tornos what he anticipates will be the most exciting aspect of this expanded role: In this newly-created role, I will continue to drive our global business forward and will take further steps to integrate all aspects as we innovate and execute on our mission to alleviate pain and improve the quality of life for people around the world. We already have strong leaders in place for all key functions, and Im proud to work alongside them to further integrate activities, from global operations to clinical and medical education to global research and development and new product development., Also, Im excited to have more direct engagement with the EMEA team and to partner with the businesses as we work towards the pandemic recovery. WARSAW Zimmer Biomet Holdings, Inc. recently announced that Ivan Tornos has been appointed to the newly created position of Chief Operating Officer. Ivan Tornos 4mo Report this post One more day at the Smart Solutions, dream-building factory! WARSAW, Ind., October 31, 2018 - Zimmer Biomet Holdings, Inc. , a global leader in musculoskeletal healthcare, today announced Ivan Tornos, previously Worldwide . "As we continue to transform the Company, having Ivan at the helm in this newly-created and expanded role to drive forward, align and execute on our operations helps ensure we continue to deliver for our customers, patients and shareholders.". Mr. Tornos owns over 3,538 units of Zimmer Biomet Inc stockworth over 1,679,896$ and over the last 3 years he sold ZBH stock worth over 0$. For a list and description of some of such risks and uncertainties, see Zimmer Biomet's periodic reports filed with theU.S.Securities and Exchange Commission (SEC). According to the press release Tornos, who will continue to report directly to Bryan Hanson, President and CEO, and will be responsible for overseeing all global businesses at Zimmer Biomet, as well as leading the global operations, clinical and medical education and global R&D and New Product Development functions. Tornos has been serving as Group President, Global Businesses, and the Americas. . Sues DePuy Synthes for Patent Infringement. (RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) Friday announced the appointment of Ivan Tornos as Chief Operating Officer, a newly created position. We collaborate with healthcare professionals around the globe to advance the pace of innovation. We have operations in more than 25 countries around the world and sell products in more than 100 countries. Tornos has been serving as Group. Mr. Ivan Tornos is a Chief Operating Officer at Zimmer Biomet Holdings, Inc., a President at Biomet, Inc. and a President at Biomet Leasing, Inc. Mr. Tornos was previously employed as a President-Europe, Middle East & Africa Regions by C. R. Bard, Inc. warsaw, ind., october 31, 2018 - zimmer biomet holdings, inc. (nyse and six: zbh), a global leader in musculoskeletal healthcare, today announced ivan tornos, previously worldwide president for urology/medical and critical care at becton, dickinson and company (nyse: bdx), will join zimmer biomet as group president, orthopedics, effective "We wish Didier continued success in his next career endeavor," said Mr. Hanson. Mar. 574-371-9480 Mr. Tornos is an alumnus of the Harvard Business School, having graduated from the Advanced Management Program and he also completed leadership and management programs at the Cox School of Business of Southern Methodist University. Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later wasnamedGroup President, Global Businesses and the Americas. This cautionary note is applicable to all forward-looking statements contained in this news release. In this new role, he will continue to report directly to Bryan Hanson, President and CEO, and will be responsible for overseeing all global businesses at Zimmer Biomet, as well as leading the global operations, clinical and medical education and global R&D and New Product Development functions. Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating . zimmer biomet holdings inc. announced it has appointed ivan tornos as chief operating officer, a newly created position in the company, according to a company press release.the release noted. 19, 2021, 07:00 AM WARSAW, Ind., March 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Is this happening to you frequently? Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomets expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Founded in 1927 and headquartered inWarsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. cole.lannum@zimmerbiomet.com, Derek Davis Of this total $785,000 was received as a salary, $808,356 was received as a bonus, $1,600,020 was received in stock options, $1,600,089 was awarded as stock and $85,444 came from other types of compensation. In the near-term, Mr. Deltort will continue to oversee marketing, sales and distribution of products, services and solutions in the EMEA region, partnering closely with Mr. Tornos. to joining Zimmer Biomet, Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. 77% of retail CFD accounts lose money, Zimmer Biomet Reports Positive Data From Mymobility Clinical Study, Zimmer Biomet Announces One-Year Data from mymobility Clinical Study at 2022 AAHKS Annual Meeting, Barclays Sticks to Their Sell Rating for Zimmer Biomet Holdings (ZBH), Robert W. Baird Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH), Expert Ratings for Zimmer Biomet Holdings, Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD) and Zimmer Biomet Holdings (ZBH), Needham Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH), Zimmer Biomet (ZBH) Q3 Earnings Beat, Gross Margin Falls, Registration on or use of this site constitutes acceptance of our. In the new role, in addition to his continued leadership of the Americas region, he will now oversee Europe, Middle East, and Africa (EMEA) region. 4mo. businesses as well as our Americas region. (WARSAW, IN) March 19, 2021Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. WARSAW,Ind., March 19, 2021 /PRNewswire/ --Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. . Robotic Assist vs Free-Hand Screw Placement: Which Wins? Mr. Tornos owns over 3,538 units of Zimmer Biomet Inc stock worth over $1,589,121 and over the last 4 years he sold ZBH stock worth over $0. Monica Kendrick Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology/Medical and Critical Care Division of Becton, Dickinson and Company. Earlier, he was with C.R. 574-372-4250 These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC. . Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. Zimmer Biomet Holdings, Inc., a provider of musculoskeletal healthcare, has announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. Bard, one of which was President, Europe, Middle East and Africa Regions. As a Spaniard, I have a true passion for my home continent and I am looking forward to being more directly engaged with the EMEA team., As COO, I will continue the strong momentum weve started with the Global Businesses and the Americas teams. Privacy Policy, Winner of the MORE Award in Journalistic Excellence in Orthopedics. If you have an ad-blocker enabled you may be blocked from proceeding. Arjun Ishwar joins Miach Orthopaedics, Inc. as vice president of sales and marketing. Ivan Tornos Chief Operating Officer Ivan Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. This cautionary statement is applicable to all forward-looking statements contained in this release. Mr. Tornos joined Zimmer Biomet in November 2018 as Group To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. This site uses Akismet to reduce spam. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Copyright 2022 RRY Publications, LLC. "As we continue to transform the Company, having Ivan at the helm in this newly-created and expanded role to drive forward, align and execute on our operations helps ensure we continue to deliver for our customers, patients and shareholders. Mr. Tornos is an alumnus of the Harvard Business School having graduated from the Advanced Management Program (AMP 187) and also completed Leadership and Management programs at the Cox School of Business of Southern Methodist University. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging Segments of Covidien International. All Rights Reserved. In addition to his continued leadership of the Americas region, Mr. Tornos will now have oversight of the Europe, Middle East and Africa (EMEA) region, with the President of EMEA reporting directly to him. "On behalf of the Zimmer Biomet team, I want to thank him for his strong and collaborative partnership over the last three years and for his commitment to ensuring a smooth and successful transition of his responsibilities.". monica.kendrick@zimmerbiomet.com, Investors WARSAW, Ind., March 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. , a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the. Required fields are marked *. Ivan Tornos' Post. This information is derived from proxy statements filed for the 2020 fiscal year. WARSAW, Ind., October 31, 2018 - Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced Ivan Tornos, previously Worldwide President for Urology/Medical and Critical Care at Becton, Dickinson and Company (NYSE: BDX), will join Zimmer Biomet as Group President, Orthopedics, effective November 1, 2018. The estimated Net Worth of Ivan Tornos is at least 5.88 $ dollars as of 3 December 2021. The result, which beat the 5.8 billion analyst consensus, was driven by growth in Siemens Healthineers' imaging unit, its largest business.Unit sales grew 17.3%, or 8.1% on a comparable basis, driven by demand for magnetic resonance imaging and . We collaborate with healthcare professionals around the globe to advance the pace of innovation. "Since joining Zimmer Biomet, Ivan has made tremendous contributions toward the strategic evolution of our business, delivering consistent results across the board," said Mr. Hanson. LRE Systems restorative elbow joint system brought to global market via a strategic partnership with OCG. View original content to download multimedia:http://www.prnewswire.com/news-releases/zimmer-biomet-expands-role-for-ivan-tornos-appointing-him-to-new-chief-operating-officer-post-301250621.html, http://www.prnewswire.com/news-releases/zimmer-biomet-expands-role-for-ivan-tornos-appointing-him-to-new-chief-operating-officer-post-301250621.html, California Transparency in Supply Chain Act Disclosure. Cautionary Statement Regarding Forward-Looking Statements Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. Further, the musculoskeletal healthcare provider said, Didier Deltort, who has served as the President of EMEA since August 2018, will be departing Zimmer Biomet for another professional appointment. Tornos, who joined Zimmer Biomet in November 2018 as Group President, Orthopedics, became Group President, Global Businesses and the Americas just one year later. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. 03/11: . For a list and description of some of such risks and uncertainties, see Zimmer Biomets periodic reports filed with the U.S. Securities and Exchange Commission (SEC). Readers of this release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. Zimmer Biomet has named Ivan Tornos Chief Operating Officer, a new position created within the company. CMS Creating Rule for Expedited Medicare Coverage, Cartilage Repair Rising, Reop Rates Falling: New UCSF Study, Taking Another, Deeper Look at Vertebral Body Tethering. This release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. WARSAW, Ind., October 31, 2018 - Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced Ivan Tornos, previously Worldwide President for Urology/Medical and Critical Care at Becton, Dickinson and Company (NYSE: BDX), will join Zimmer Biomet as Group President, Orthopedics, effective November 1, 2018. He will also have responsibility for the Europe, Middle East and Africa (EMEA) region as well . For more information, visitwww.zimmerbiomet.comor follow Zimmer Biomet on Twitter atwww.twitter.com/zimmerbiomet. Please disable your ad-blocker and refresh. This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Together with healthcare professionals, we help millions of people live better lives. Ivan Tornos Chief Operating Officer Ivan Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. Before that, Mr. Tornos served as International Vice President, Business Development and Strategy with Baxter International Inc. and prior to that, he spent 11 years with Johnson & Johnson in positions of increasing responsibility. Joining me today are Bryan Hanson, our Chairman, President, and CEO; EVP and CFO, Suki Upadhyay; and COO, Ivan Tornos. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. AboutZimmer Biomet Ivan Tornos / Courtesy of Zimmer BiometHoldings, Inc. Q4 insights: Siemens Healthineers, a market leader in diagnostic imaging, has posted quarterly revenue of 6 billion for the first time. Zimmer Biomet Holdings, Inc. announced one-year data from a multicenter, prospective, randomized controlled trial to evaluate the impact of mymobility with Apple Watch, a first-of-its-kind remote care management platform. Please. His career prior to C.R. Welcome to Zimmer Biomet's third quarter 2022 earnings conference call. Recommandations des analystes sur ZIMMER BIOMET HOLDINGS: 03/11: Zimmer Biomet Holdings : Citigroup maintient sa recommandation ne.. ZM. Ivan Tornos is Chief Operating Officer at Zimmer Biomet. Ivan Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. Zimmer Biomet Holdings, Inc. announced Ivan Tornos, previously Worldwide President for Urology/Medical and Critical Care at Becton, Dickinson and Company, will join Zimmer Biomet as Group President,. Additionally, Im excited to accelerate innovation across our integrated portfolio of robotics and digital technologies as we work towards delivery of data-powered clinical insights that are shared seamlessly across the patient journey., Your email address will not be published. Mr. Tornos has joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care . Forward-looking statements speak only as of the date made. In addition, he makes $4,196,910 as Group President - Global Businesses and Americas at Zimmer Biomet Inc. Mr. Tornos comes to Zimmer Biomet having served for more than two decades in various global roles for Fortune 50 to 500 companies. WARSAW, Ind., October 31, 2018 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced Ivan Tornos, previously Worldwide President for Urology/Medical and Critical Care at Becton, Dickinson and Company (NYSE: BDX), will join Zimmer Biomet as Group President, Orthopedics, effective November 1, 2018. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. Zimmer Biomet (NYSE:ZBH) announces that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. Axis Spine, a spinal implant manufacturer, has closed a successful $12.5 million Series A financing round. Bard involved serving as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. Ivans exceptional track record of executing on commercial strategies and driving growth and profitability will be critical to Zimmer Biomet as we continue our focus on achieving sustained performance in the business.. As Chief Operating Officer at ZIMMER BIOMET HOLDINGS INC, Ivan Tornos made $4,878,909 in total compensation. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings. Save my name, email, and website in this browser for the next time I comment. 321,958 followers. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Your email address will not be published. Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post Tornos Continues to Lead Global Businesses and Americas; Will Now Also Oversee Europe,. Axis Spine Raises $12.5M in Series A Financing Round, Arjun Ishwar Joins Miach Orthopaedics as VP Sales & Marketing, New Mesenchymal Stem Cell Company Launched, LRE System and Ortho Consulting Group Partnering, FDA Clears New Extremity Tendon Repair System, Patrick Seiler Is Spire Orthopedics New CFO, Using Amniotic Membrane Barrier in ALIF Surgery, A Giant Upon Whose Shoulders We Stand Has Died, This Spine Surgeon Wrote THE Book on Mental Health, Patrick Sweeney, M.D. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. His responsibilities now extend beyond the Americas region, as he will now have oversight of the Europe, Middle East and Africa (EMEA) region, with the President of EMEA reporting directly to him., "Since joining Zimmer Biomet, Ivan has made tremendous contributions toward the strategic evolution of our business, delivering consistent results across the board," said Hanson. Ivan Tornos, group president of Global Businesses and the Americas at Warsaw, Indiana-based Zimmer Biomet, has been named as the companys Chief Operating Officer (COO)a newly-created position. Tornos joined the Warsaw, Indiana-based company in November 2018 as president of the orthopedics group, became group president of global business and the Americas in 2019 and was promoted to serve as chief operating officer a new position at Zimmer Biomet in March 2021. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. Before joining C.R. Ivan Tornos made $4,142,242 in total compensation as Group President, Global Businesses and Americas at Zimmer Biomet Holdings Inc in 2020.$1,381,602 was received as Total Cash, $2,650,078 was received as Equity and $110,562 was received as Pension and other forms of compensation. derek.davis@zimmerbiomet.com, California Transparency in Supply Chain Act Disclosure. About Ivan Tornos He was appointed as Chief Operating Officer in March 2021. The estimated Net Worth of Ivan Tornos is at least $5.79 Million dollars as of 3 December 2021. For more information, visit www.zimmerbiomet.com. He was appointed as Chief Operating Officer in March 2021. Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. Prior to that, he was with C.R. Plus500. Tue, April 13th, 2021 Ivan Tornos / Courtesy of Zimmer BiometHoldings, Inc. Ivan Tornos, group president of Global Businesses and the Americas at Warsaw, Indiana-based Zimmer Biomet, has been named as the company's Chief Operating Officer (COO)a newly-created position. Together with healthcare professionals, we help millions of people live better lives. ; Tornos joined Zimmer Biomet in November 2018 as Group President . Go to DeviceTalks.com to hear the entire conversation. Ivan Tornos is Chief Operating Officer at Zimmer Biomet Holdings Inc. See Ivan Tornos's compensation, career history, education, & memberships. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet. Ivan Tornos: Chief Operating Officer: Angela Main: Chief Compliance Officer & Senior Vice President: More about the . Ivan Tornos: Chief Operating Officer: He will lead all global business, global operations, clinical and medical education, global research and development, and new product development. The ZBEdge Connected Intelligence Suite enables healthcare professionals to connect the dots between procedural and patient data at every stage of the surgical journey. New system for the repair of specific lacerated or severed tendons in adults receives 510(k) clearance. He also held the position of International Vice President, Business Development and Strategy with Baxter International Inc., and before that Tornos spent over a decade in international leadership with Johnson & Johnson., Ivan Tornos graduated from Harvard Business School and completed leadership and management programs at the Cox School of Business of Southern Methodist University. He also served as International Vice President, Business Development and Strategy with Baxter International Inc., and prior to that he spent over a decade in leadership assignments around the globe with Johnson & Johnson. Welcome to Zimmer Biomet's third quarter 2022 earnings conference call. | April 13, 2022 Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Ivan is a great addition to our leadership team, bringing deep medical technology expertise and a strong history of successfully managing complex businesses across several continents, said Bryan Hanson, President and CEO of Zimmer Biomet. We have operations in more than 25 countries around the world and sell products in more than 100 countries. ZBEdge technologies are designed with the dual goals of reducing variability of care and enhancing outcomes," said Ivan Tornos, Chief Operating Officer at Zimmer Biomet. In terms of my first steps in this expanded role, I am diving in to facilitate integration across our business. Liked by Ivan Tornos Join now to see all activity Experience Zimmer Biomet 4 years 1 month CHIEF OPERATING OFFICER Mar 2021 - Present1 year 9 months United States Accountability for all. (RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) Friday announced the appointment of Ivan Tornos as Chief Operating Officer, a newly created position.
How Long Can Lobster Live, Herdez Cilantro Lime Salsa Cremosa Chicken Recipes, How Old Is Scottie Scheffler, Beauty Bar Terre Haute, Bike Park Wales Best Trails, Exposed Brick Wall Exterior, Yamaha Sr400 For Sale,